Seroflo
Fluticasone Propionate · Salmeterol
Developed to mitigate chronic airway swelling to support lung ventilation stability and alleviate coughing.
- Category
- Allergy Relief
- Active ingredients
- Fluticasone Propionate · Salmeterol
- Route
- Inhalation use
- Form
- Inhaler
- Strengths
- 25mcg + 250mcg
Prescription and consultation requirements for Seroflo vary by destination and are determined by the fulfilment partner.
Seroflo details
- Conditions
- Asthma · Chronic Obstructive Pulmonary Disease
- Alternative names
- fluticasone, salmeterol
- Therapeutic class
- Corticosteroid, Long-Acting Beta2-Adrenergic Agonist Combination
- Pharmacological class
- Inhaled Bronchodilator and Corticosteroid
- Contraindications
- status asthmaticus; severe milk protein hypersensitivity
- Minor side effects
- hoarseness; throat irritation; cough
- Moderate side effects
- oral thrush; headache; sinusitis
- Dosage forms
- Inhaler
- Administration route
- Inhalation use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Cipla Ltd
- Onset Time
- 30–60 minutes
- Duration
- 12 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- Ketoconazole; Beta Blockers; Ritonavir
- Age restrictions
- Approved for children over four years and adults.
- Pregnancy and breastfeeding
- TGA Category C: Use if benefit outweighs risk. Breastfeeding: Consult a doctor.
Serious side effects
paradoxical bronchospasm, requires immediate medical attention; pneumonia, requires immediate medical attention
Patient summary
developed to mitigate chronic airway swelling to support lung ventilation stability and alleviate coughing.
Mechanism of action
Fluticasone suppresses tissue inflammation, while salmeterol relaxes bronchial smooth muscles for twelve hours.